Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,145 | 70 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $478.99 | 29 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $130.53 | 12 | $0 (2018) |
| Astellas Pharma US Inc | $125.36 | 8 | $0 (2018) |
| Allergan, Inc. | $99.66 | 5 | $0 (2020) |
| PFIZER INC. | $92.66 | 4 | $0 (2017) |
| The Medicines Company | $89.48 | 5 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $37.05 | 2 | $0 (2019) |
| UCB, Inc. | $35.65 | 2 | $0 (2017) |
| iRhythm Technologies, Inc. | $19.06 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $18.43 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $46.01 | 2 | Allergan, Inc. ($23.34) |
| 2019 | $358.88 | 22 | Janssen Pharmaceuticals, Inc ($228.11) |
| 2018 | $133.93 | 7 | Janssen Pharmaceuticals, Inc ($40.47) |
| 2017 | $606.29 | 39 | Janssen Pharmaceuticals, Inc ($187.74) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/22/2020 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/21/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $1.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/11/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/10/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/28/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/21/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/11/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/02/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/02/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/14/2019 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/02/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/17/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/21/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/21/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $0.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/06/2019 | Smith+Nephew, Inc. | Santyl (Drug), REGRANEX | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Pharma Product | ||||||
| 10/02/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 43 | 116 | $13,089 | $7,582 |
| 2022 | 2 | 26 | 72 | $10,024 | $6,162 |
| 2021 | 4 | 95 | 206 | $21,177 | $14,020 |
| 2020 | 5 | 260 | 637 | $71,138 | $51,842 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 18 | 67 | $7,417 | $4,742 | 63.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 33 | $2,472 | $1,744 | 70.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 16 | $3,200 | $1,096 | 34.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 15 | 49 | $5,424 | $4,065 | 74.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 23 | $4,600 | $2,097 | 45.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 32 | 75 | $8,400 | $5,984 | 71.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 31 | 89 | $6,976 | $4,652 | 66.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 21 | 21 | $2,601 | $1,722 | 66.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 21 | $3,200 | $1,662 | 51.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 69 | 298 | $22,785 | $17,740 | 77.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 82 | 207 | $22,697 | $17,611 | 77.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 22 | 43 | $12,700 | $7,215 | 56.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 62 | 64 | $7,379 | $5,728 | 77.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 25 | 25 | $5,576 | $3,548 | 63.6% |
About Dr. Joshua Starbuck, MD
Dr. Joshua Starbuck, MD is a Hospitalist healthcare provider based in Makawao, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2012. The National Provider Identifier (NPI) number assigned to this provider is 1114287828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Starbuck, MD has received a total of $1,145 in payments from pharmaceutical and medical device companies, with $46.01 received in 2020. These payments were reported across 70 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,145).
As a Medicare-enrolled provider, Starbuck has provided services to 424 Medicare beneficiaries, totaling 1,031 services with total Medicare billing of $79,606. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Makawao, HI
- Active Since 05/29/2012
- Last Updated 01/30/2023
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1114287828
Products in Payments
- XARELTO (Drug) $478.99
- ELIQUIS (Drug) $223.19
- Lexiscan (Drug) $94.83
- MINOCIN IV (Drug) $89.48
- AVYCAZ (Drug) $45.86
- BRILINTA (Drug) $37.05
- Vimpat (Drug) $35.65
- TEFLARO (Drug) $33.34
- DALVANCE (Drug) $20.46
- ZIO Patch (Device) $19.06
- ENTRESTO (Drug) $18.43
- Santyl (Drug) $18.24
- CRESEMBA (Drug) $15.36
- Cresemba (Drug) $15.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.